Sabrina Crivellaro

Turin, 10043, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Mechanisms of p53 Functional De-Regulation: Role of the IκB-α/p53 Complex.

Mechanisms of p53 Functional De-Regulation: Role of the IκB-α/p53 Complex.

Journal: International journal of molecular sciences
Published: September 08, 2016

Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones.

Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones.

Journal: Oncotarget
Published: June 14, 2016

The BCR-ABL/NF-κB signal transduction network: a long lasting relationship in Philadelphia positive Leukemias.

The BCR-ABL/NF-κB signal transduction network: a long lasting relationship in Philadelphia positive Leukemias.

Journal: Oncotarget
Published: April 17, 2016

IκB-α: At the crossroad between oncogenic and tumor-suppressive signals.

IκB-α: At the crossroad between oncogenic and tumor-suppressive signals.

Journal: Oncology letters
Published: November 23, 2015

Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias.

Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias.

Journal: Advances in hematology
Published: October 27, 2015

The targetable role of herpes virus-associated ubiquitin-specific protease (HAUSP) in p190 BCR-ABL leukemia.

The targetable role of herpes virus-associated ubiquitin-specific protease (HAUSP) in p190 BCR-ABL leukemia.

Journal: Oncology letters
Published: September 11, 2015

The non-genomic loss of function of tumor suppressors: an essential role in the pathogenesis of chronic myeloid leukemia chronic phase.

The non-genomic loss of function of tumor suppressors: an essential role in the pathogenesis of chronic myeloid leukemia chronic phase.

Journal: BMC cancer
Published: August 21, 2015

Unleashing the Guardian: The Targetable BCR-ABL/HAUSP/PML/PTEN Network in Chronic Myeloid Leukemia.

Unleashing the Guardian: The Targetable BCR-ABL/HAUSP/PML/PTEN Network in Chronic Myeloid Leukemia.

Journal: Current drug targets
Published: July 07, 2015

New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemia.

New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemia.

Journal: Oncoscience
Published: June 29, 2015

The Role of PTEN in Myeloid Malignancies.

The Role of PTEN in Myeloid Malignancies.

Journal: Hematology reports
Published: May 21, 2015

Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBα mediated p53 nuclear exclusion.

Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBα mediated p53 nuclear exclusion.

Journal: Oncotarget
Published: February 05, 2015

BCR-ABL inactivates cytosolic PTEN through Casein Kinase II mediated tail phosphorylation.

BCR-ABL inactivates cytosolic PTEN through Casein Kinase II mediated tail phosphorylation.

Journal: Cell cycle (Georgetown, Tex.)
Published: January 22, 2015
Showing 1-12 of 16

Last Updated: 09/26/2026